Assembly Biosciences, Inc. (ASMB) News

Assembly Biosciences, Inc. (ASMB): $3.25

0.02 (+0.62%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter ASMB News Items

ASMB News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ASMB News Highlights

  • For ASMB, its 30 day story count is now at 7.
  • Over the past 15 days, the trend for ASMB's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
  • The most mentioned tickers in articles about ASMB are DOW, AIM and ALT.

Latest ASMB News From Around the Web

Below are the latest news stories about Assembly Biosciences Inc that investors may wish to consider to help them evaluate ASMB as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time for another eventful day of trading and we're kicking it off with a look at the biggest pre-market stock movers for Thursday.

William White on InvestorPlace | September 2, 2021

Mid-Afternoon Market Update: Dow Rises 90 Points; Kirkland's Shares Spike Higher

Toward the end of trading Thursday, the Dow traded up 0.25% to 35,402.54 while the NASDAQ rose 0.05% to 15,316.38. The S&P also rose, gaining 0.13% to 4,530.11. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 39,399,080 cases with around 642,090 deaths. India confirmed a total of at least 32,857,930 cases and 439,520 deaths, while Brazil reported over 20,804,210 COVID-19 cases with 581,150 deaths. In total, there were at least 218,516,630 cases

Yahoo | September 2, 2021

Mid-Day Market Update: Crude Oil Jumps Over 2%; Assembly Biosciences Shares Plunge

Midway through trading Thursday, the Dow traded up 0.42% to 35,461.47 while the NASDAQ rose 0.39% to 15,369.38. The S&P also rose, gaining 0.38% to 4,541.06. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 39,399,080 cases with around 642,090 deaths. India confirmed a total of at least 32,857,930 cases and 439,520 deaths, while Brazil reported over 20,804,210 COVID-19 cases with 581,150 deaths. In total, there were at least 218,516,630 cases of

Yahoo | September 2, 2021

Mid-Morning Market Update: Markets Open Higher; Hormel Foods Cuts Earnings Outlook

Following the market opening Thursday, the Dow traded up 0.18% to 35,377.03 while the NASDAQ rose 0.23% to 15,345.05. The S&P also rose, gaining 0.27% to 4,536.45. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 39,399,080 cases with around 642,090 deaths. India confirmed a total of at least 32,857,930 cases and 439,520 deaths, while Brazil reported over 20,804,210 COVID-19 cases with 581,150 deaths. In total, there were at least 218,516,630 cas

Yahoo | September 2, 2021

Assembly Bio Stock Tumbles On Discontinuation Of Hepatitis B Trial

Assembly Biosciences Inc (NASDAQ: ASMB) has decided to discontinue the development of ABI-H2158 (2158) following the observation of elevated alanine transaminase (ALT) levels consistent with drug-induced hepatotoxicity (liver damage) in the Phase 2 trial. The FDA noted that 2158 would also be placed on clinical hold. The Phase 2 study enrolled 88 treatment-naïve patients with HCV-positive or HCV-negative chronic hepatitis B infection without cirrhosis. In the study, two patients receiving 2158 e

Yahoo | September 2, 2021

Assembly Bio Announces Decision to Discontinue Clinical Development of ABI-H2158

--Decision follows observation of elevated alanine transaminase (ALT) levels in Phase 2 study--Company will focus on advancing ongoing triple combination studies and earlier pipeline candidates SOUTH SAN FRANCISCO, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today announced its decision to discontinue development of ABI-H2158 (2158) following the

Yahoo | September 1, 2021

Assembly Bio Selects Fourth HBV Core Inhibitor Candidate for Advancement Into Clinical Development

SOUTH SAN FRANCISCO, Calif., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today announced it has selected a fourth core inhibitor candidate, ABI-4334 (4334), that has been optimized for potency, to advance into clinical development. The company is conducting preclinical work, with the aim of completing regulatory filings and initiating clinical studies as soon as possible in 2022.

Intrado Digital Media | August 18, 2021

Assembly Biosciences Reports Second Quarter 2021 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today reported financial results and recent highlights for the second quarter ended June 30, 2021.

Intrado Digital Media | August 5, 2021

Assembly Biosciences (ASMB) Reports Q2 Loss, Lags Revenue Estimates

Assembly Biosciences (ASMB) delivered earnings and revenue surprises of 14.06% and -100.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | August 5, 2021

Assembly Bio Announces Key Promotions to Leadership Team

SOUTH SAN FRANCISCO, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today announced the promotions of Jason Okazaki to chief operating officer and Michael Samar to chief financial officer. Mr. Okazaki joined Assembly Bio in 2020 as chief legal and business officer responsible for leading and executing strategic collaborations and transactions. Since joining Assembly Bio in 2017, Mr. Samar has led the companys financial and business operations, serving most recently as senior vice president of finance and business operations.

Intrado Digital Media | August 3, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6522 seconds.